{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:46Z","timestamp":1787020186422,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immune Checkpoint Inhibitors (ICPIs) are promising new drugs in treatment of advanced tumours targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein-1 (PD1) or its ligand (PDL-1). Ipilimumab is a monoclonal antibody targeting the CTLA-4 receptor used in treatment of metastatic melanoma. By increasing activity of the immune system, ICPIs lead to immune-related adverse events, such as dermatitis, colitis or hepatitis. ICPIs-related kidney adverse events are rare and acute tubulointerstitial nephritis with or without granuloma have mainly been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report a case of acute kidney injury in a patient with melanoma treated by ipilimumab. Kidney biopsy revealed acute interlobular and juxtaglomerular granulomatous arteritis, which has not yet been reported in patients treated by ICPIs. Kidney function partially recovered after ipilimumab discontinuation and oral prednisone. Unfortunately, the patient died a few months later from progression of his melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights a new mechanism of acute kidney injury related to ICPIs and supports the interest of kidney biopsy in case of ICPIs related acute renal failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-019-1552-2","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T04:04:22Z","timestamp":1570766662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Ipilimumab-induced renal granulomatous arteritis: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5985-8042","authenticated-orcid":false,"given":"Mathilde","family":"Lemoine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Dilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Curie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Hanoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Grang\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Guerrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"issue":"7","key":"1552_CR1","doi-asserted-by":"publisher","first-page":"e0160221","DOI":"10.1371\/journal.pone.0160221","volume":"11","author":"Noha Abdel-Wahab","year":"2016","unstructured":"Abdel-Wahab N, Shah M, Suarez-Almazor ME. Adverse events associated with immune checkpoint blockade in patients with Cancer: a systematic review of case reports. Nishikawa H, \u00e9diteur. PLOS ONE 29 juill 2016;11(7):e0160221.","journal-title":"PLOS ONE"},{"key":"1552_CR2","doi-asserted-by":"crossref","unstructured":"Izzedine H, Mateus C, Boutros C, Robert C, Rouvier P, Amoura Z, et al. Renal effects of immune checkpoint inhibitors. Nephrol Dial Transplant 26 d\u00e9c. 2016; gfw382.","DOI":"10.1093\/ndt\/gfw382"},{"issue":"3","key":"1552_CR3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","volume":"90","author":"FB Cortazar","year":"2016","unstructured":"Cortazar FB, Marrone KA, Troxell ML, Ralto KM, Hoenig MP, Brahmer JR, et al. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int sept. 2016;90(3):638\u201347.","journal-title":"Kidney Int sept"},{"issue":"2","key":"1552_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMc0904283","volume":"361","author":"F Fadel","year":"2009","unstructured":"Fadel F, Karoui KE, Knebelmann B. Anti-CTLA4 antibody\u2013induced lupus nephritis. N Engl J Med 9 juill. 2009;361(2):211\u20132.","journal-title":"N Engl J Med 9 juill"},{"issue":"4","key":"1552_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1053\/j.ajkd.2017.04.026","volume":"70","author":"A Kitchlu","year":"2017","unstructured":"Kitchlu A, Fingrut W, Avila-Casado C, Chan CT, Crump M, Hogg D, et al. Nephrotic syndrome with Cancer immunotherapies: a report of 2 cases. Am J Kidney Dis oct. 2017;70(4):581\u20135.","journal-title":"Am J Kidney Dis oct"},{"key":"1552_CR6","first-page":"1):1","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum janv. 2013;65:1):1\u201311.","journal-title":"Arthritis Rheum janv"},{"issue":"4","key":"1552_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40620-016-0303-8","volume":"29","author":"F Maritati","year":"2016","unstructured":"Maritati F, Iannuzzella F, Pavia MP, Pasquali S, Vaglio A. Kidney involvement in medium- and large-vessel vasculitis. J Nephrol ao\u00fbt. 2016;29(4):495\u2013505.","journal-title":"J Nephrol ao\u00fbt"},{"issue":"2","key":"1552_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/j.ajkd.2011.09.025","volume":"59","author":"V Agrawal","year":"2012","unstructured":"Agrawal V, Crisi GM, D\u2019Agati VD, Freda BJ. Renal sarcoidosis presenting as acute kidney injury with granulomatous interstitial nephritis and Vasculitis. Am J Kidney Dis 1 f\u00e9vr. 2012;59(2):303\u20138.","journal-title":"Am J Kidney Dis 1 f\u00e9vr"},{"key":"1552_CR9","doi-asserted-by":"crossref","unstructured":"Maanaoui M, Saint-Jacques C, Gnemmi V, Frimat M, Lionet A, Hazzan M, et al. Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma. Medicine (Baltimore) [Internet]. 23 juin 2017 [cit\u00e9 1 nov 2018];96(25). Disponible sur: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5484213\/","DOI":"10.1097\/MD.0000000000007196"},{"issue":"9","key":"1552_CR10","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s10067-018-4177-0","volume":"37","author":"A Daxini","year":"2018","unstructured":"Daxini A, Cronin K, Sreih AG. Vasculitis associated with immune checkpoint inhibitors\u2014a systematic review. Clin Rheumatol sept. 2018;37(9):2579\u201384.","journal-title":"Clin Rheumatol sept"},{"issue":"3","key":"1552_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/art.38282","volume":"66","author":"BL Goldstein","year":"2014","unstructured":"Goldstein BL, Gedmintas L, Todd DJ. Drug-associated polymyalgia Rheumatica\/Giant cell arteritis occurring in two patients after treatment with Ipilimumab, an antagonist of CTLA-4: concise communication. Arthritis Rheumatol mars. 2014;66(3):768\u20139.","journal-title":"Arthritis Rheumatol mars"},{"issue":"2","key":"1552_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/j.ajkd.2016.02.057","volume":"68","author":"AC Shirali","year":"2016","unstructured":"Shirali AC, Perazella MA, Gettinger S. Association of Acute Interstitial Nephritis with Programmed Cell Death 1 inhibitor therapy in lung Cancer patients. Am J Kidney Dis ao\u00fbt. 2016;68(2):287\u201391.","journal-title":"Am J Kidney Dis ao\u00fbt"},{"issue":"4","key":"1552_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10637-014-0092-7","volume":"32","author":"H Izzedine","year":"2014","unstructured":"Izzedine H, Gueutin V, Gharbi C, Mateus C, Robert C, Routier E, et al. Kidney injuries related to ipilimumab. Invest New Drugs ao\u00fbt. 2014;32(4):769\u201373.","journal-title":"Invest New Drugs ao\u00fbt"},{"issue":"3","key":"1552_CR14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.kint.2016.05.024","volume":"90","author":"MA Perazella","year":"2016","unstructured":"Perazella MA. Checkmate: kidney injury associated with targeted cancer immunotherapy. Kidney Int. sept. 2016;90(3):474\u20136.","journal-title":"Kidney Int. sept"},{"issue":"12","key":"1552_CR15","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/rheumatology\/kep280","volume":"48","author":"L Kamesh","year":"2009","unstructured":"Kamesh L, Heward JM, Williams JM, Gough SCL, Chavele K-M, Salama A, et al. CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis. Rheumatology 1 d\u00e9c. 2009;48(12):1502\u20135.","journal-title":"Rheumatology 1 d\u00e9c"},{"issue":"1","key":"1552_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2008.03.506","volume":"128","author":"MC Slot","year":"2008","unstructured":"Slot MC, Sokolowska MG, Savelkouls KG, Janssen RGJH, Damoiseaux JGMC, Cohen Tervaert JW. Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis. Clin Immunol juill. 2008;128(1):39\u201345.","journal-title":"Clin Immunol juill"},{"key":"1552_CR17","doi-asserted-by":"crossref","unstructured":"Shafqat H, Gourdin T, Sion A. Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1\/PD-L1 therapy. Semin Oncol [Internet]. oct 2018 [cit\u00e9 12 nov 2018]; Disponible sur: \n                    https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775418300095","DOI":"10.1053\/j.seminoncol.2018.07.003"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1552-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1552-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1552-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T19:11:39Z","timestamp":1602270699000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1552-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1552"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1552-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"13 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s son for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"366"}}